.avif)
SAN DIEGO, Calif. – July 16, 2013 – Assay Depot Inc., the world’s leading provider of outsourced scientific services today announced the launch of MXIS (Market Exchange for Innovative Services), a virtual outsourcing platform for Pfizer scientists. MXIS, an Assay Depot Enterprise Solution, brings together research services from thousands of global vendors (aka CROs) into one secure website, enabling Pfizer scientists to communicate with any research vendor.
Using MXIS, Pfizer researchers can query the marketplace for services, request quotes, find and compare outsourced services, place orders, track projects, create reports and much more. It is a centralized IT platform that enables Pfizer scientists to create, customize and purchase any research service, and to manage the sourcing project from initial request to service delivery.
“MXIS gives scientists rapid and efficient access to innovative research services from any global service provider in Assay Depot’s network,” said Robert Kaufman, Assay Depot’s VP of Engineering. “With just a few mouse clicks, scientists can quickly order or custom design a research service and then work closely with their outsourcing partners, significantly reducing the time it takes to complete a research project.”
MXIS has many of the same features as today’s popular consumer websites. Researchers can access it from anywhere they access the Internet, including tablets and mobile devices. They also can view ratings and reviews and then add research services and products to their shopping carts and checkout in just a few minutes.
“The MXIS sourcing system fosters transparency across Pfizer’s global research operations and external services,” said Sylvie Sakata, Pfizer’s Senior Director, External Research Solutions. “It’s a new way to empower our scientists and strengthen relationships with our external research partners, promoting innovation across the entire Pfizer research community.”
MXIS serves as a benchmarking tool and a research platform designed to benefit the entire chain of R&D stakeholders. Additional benefits include:
- Greater level of integration with preferred service providers
- Process simplification for sourcing operations
- Standardization of sourcing governance processes
- Reduction in costs by increasing efficiency and enabling apples-to-apples comparisons
- Generation of metrics/tracking that inform development of new sourcing strategies and continuously improve existing ones
Pfizer: Working Together for a Healthier World™
At Pfizer, we apply science and our global resources to improve health and well being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care. For more than 150 years, Pfizer has worked to make a difference. To learn more about our commitments, please visit us at www.pfizer.com.
.webp)
Scientist.com
Scientist.comは、科学研究のアウトソーシングという複雑な業務のために構築された、世界最大かつ初のプラットフォームです。
私たちは、製薬・バイオテクノロジー企業が、創薬や前臨床研究から臨床開発、製造、メディカルアフェアーズ、そして商業化に至るまで、パイプラインのあらゆる段階を支えるプロバイダーとの関係を構築、管理、拡大できるよう支援しています。一元化されたプラットフォームを通じて、組織は6,000社以上のグローバルなプロバイダーネットワークにアクセスし、調達ワークフローの効率化、コンプライアンスの維持、サプライヤー関係の管理を実現するとともに、データに基づいた洞察を活用して、より迅速かつ的確な意思決定を行うことが可能です。
現在、Scientist.comは世界の製薬企業トップ30社のうち24社を含む130以上のライフサイエンス関連組織を支援しており、業務の複雑さを軽減し、開発期間を短縮し、イノベーションをより迅速に患者へ届けるためのサポートを行っています。私たちの使命は、2050年までに人類のあらゆる疾患を治癒可能にすることです。